Agilent Technologies (A) Releases FY19 Earnings Guidance

Agilent Technologies (NYSE:A) issued an update on its FY19 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $3.03-3.07 for the period, compared to the Thomson Reuters consensus estimate of $3.07. The company issued revenue guidance of $5.09-5.13 billion, compared to the consensus revenue estimate of $5.19 billion.Agilent Technologies also updated its FY 2019 guidance to $3.03-3.07 EPS.

A stock opened at $76.01 on Thursday. The firm has a market cap of $23.45 billion, a PE ratio of 27.24, a price-to-earnings-growth ratio of 2.05 and a beta of 1.33. Agilent Technologies has a 52-week low of $60.42 and a 52-week high of $82.27. The company has a quick ratio of 2.79, a current ratio of 3.39 and a debt-to-equity ratio of 0.36.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Tuesday, May 14th. The medical research company reported $0.71 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.72 by ($0.01). The business had revenue of $1.24 billion for the quarter, compared to the consensus estimate of $1.27 billion. Agilent Technologies had a net margin of 22.86% and a return on equity of 19.90%. Agilent Technologies’s revenue was up 2.7% on a year-over-year basis. During the same period in the previous year, the business posted $0.65 EPS. On average, research analysts predict that Agilent Technologies will post 3.06 EPS for the current year.

The firm also recently declared a quarterly dividend, which was paid on Wednesday, April 24th. Stockholders of record on Tuesday, April 2nd were paid a dividend of $0.164 per share. This represents a $0.66 annualized dividend and a dividend yield of 0.86%. The ex-dividend date was Monday, April 1st. Agilent Technologies’s payout ratio is currently 23.66%.

A has been the subject of several analyst reports. Zacks Investment Research raised shares of Agilent Technologies from a hold rating to a buy rating and set a $79.00 price target for the company in a research note on Monday, January 21st. Deutsche Bank raised their price target on shares of Agilent Technologies from $80.00 to $85.00 and gave the company a buy rating in a research note on Tuesday, February 12th. Robert W. Baird reaffirmed a buy rating and set a $82.00 price target (up previously from $77.00) on shares of Agilent Technologies in a research note on Wednesday, February 20th. JPMorgan Chase & Co. raised their price target on shares of Agilent Technologies to $85.00 and gave the company an overweight rating in a research note on Thursday, February 21st. Finally, Barclays increased their price objective on shares of Agilent Technologies from $80.00 to $83.00 and gave the stock an overweight rating in a research report on Thursday, February 21st. Two equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Agilent Technologies presently has an average rating of Buy and a consensus price target of $86.58.

In other Agilent Technologies news, VP Mark Doak sold 16,421 shares of the firm’s stock in a transaction on Friday, February 22nd. The shares were sold at an average price of $77.95, for a total value of $1,280,016.95. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Paul N. Clark sold 2,823 shares of the firm’s stock in a transaction on Wednesday, March 27th. The stock was sold at an average price of $80.31, for a total transaction of $226,715.13. Following the completion of the sale, the director now owns 88,857 shares of the company’s stock, valued at $7,136,105.67. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 57,329 shares of company stock valued at $4,535,225.

COPYRIGHT VIOLATION WARNING: “Agilent Technologies (A) Releases FY19 Earnings Guidance” was published by Transcript Daily and is owned by of Transcript Daily. If you are accessing this piece on another domain, it was stolen and republished in violation of US & international copyright & trademark laws. The original version of this piece can be read at

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

See Also: Producer Price Index (PPI)

Earnings History and Estimates for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with's FREE daily email newsletter.